Together, evidence from human and mouse studies indicate that CAV1/2 is neuroprotective, and CAV1/2 mutations are a risk factor for ALS pathology, likely as a consequence of reduced gene expression. Here, CAV1 is linked to amyotrophic lateral sclerosis.